Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Abdelwahab Jalal"'
Autor:
Nazanene H. Esfandiari, Melvyn Rubenfire, Adam H. Neidert, Rita Hench, Abdelwahab Jalal Eldin, Rasimcan Meral, Elif A. Oral
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 5, Iss 1, Pp 1-6 (2019)
Abstract Background Metreleptin, a recombinant methionyl -human -leptin, was approved to treat patients with generalized lipodystrophy (GL) in February 2014. However, leptin therapy has been associated with the development of lymphoma. We present a u
Externí odkaz:
https://doaj.org/article/5693a61985a3401db8575fa4fdec7108
Autor:
Natalia Xavier S. de Andrade, MD, Suleyman Cem Adiyaman, MD, Bernamir De Yuksel, MD, Carla T. Ferrari, MD, Abdelwahab Jalal Eldin, MD, Basak Ozgen Saydam, MD, Canan Altay, MD, Pratima Sharma, MD, Nicole Bhave, MD, Ann Little, MD, Paul McKeever, MD, PhD, Huseyin Onay, MD, Sermin Ozkal, MD, Mustafa Secil, MD, Mustafa Nuri Yenerel, MD, Baris Akinci, MD, Elif A. Oral, MD
Publikováno v:
AACE Clinical Case Reports, Vol 6, Iss 2, Pp e79-e85 (2020)
ABSTRACT: Objective: Lipodystrophy represents a group of rare diseases characterized by loss of body fat. While patients with generalized lipodystrophy exhibit near-total lack of fat, partial lipodystrophy is associated with selective fat loss affect
Externí odkaz:
https://doaj.org/article/1bf7445361bc4ce8ba787fc77df4804a
Autor:
de Andrade, Natalia Xavier S. *, Adiyaman, Suleyman Cem *, De Yuksel, Bernamir, Ferrari, Carla T., Eldin, Abdelwahab Jalal, Saydam, Basak Ozgen, Altay, Canan, Sharma, Pratima, Bhave, Nicole, Little, Ann, McKeever, Paul, Onay, Huseyin, Ozkal, Sermin, Secil, Mustafa, Yenerel, Mustafa Nuri, Akinci, Baris, Oral, Elif A.
Publikováno v:
In AACE Clinical Case Reports March-April 2020 6(2):e79-e85
Publikováno v:
Cureus.
Autor:
Wefag Ahmed, Dhivya Pahwa, Abdelwahab Jalal, Aseih Takalloo, Vijaya Ganta, Anteneh Zenebe, Wolali Odonkor, Gail Nunlee-Bland
Publikováno v:
Endocrine Practice. 29:S43
Autor:
Eden Koo, Abdelwahab Jalal Eldin, Muhammet Ozer, Amy E. Rothberg, Baris Akinci, Nicole Miller, Rasimcan Meral, Maria C Foss-Freitas, Elif A. Oral
Publikováno v:
Obesity. 29:274-278
OBJECTIVE This study aimed to investigate the shortcoming of BMI as a measurement of adiposity in patients with familial partial lipodystrophy (FPLD). METHODS Two different matching procedures were used to compare 55 FPLD versus control patients with
Autor:
Banu Sarer Yurekli, Nicole M. Bhave, Marwan K. Tayeh, Hakan Oral, Ebru Özpelit, Ilgin Yildirim Simsir, Elif A. Oral, Zeynep Şıklar, José Jalife, Rita Hench, Ramazan Gen, Abdelwahab Jalal Eldin, Andre Monteiro da Rocha, Baris Akinci, Rasimcan Meral, Adam H. Neidert, Nilufer Ozdemir Kutbay, Suleyman Cem Adiyaman, Jeffrey W. Innis
Publikováno v:
Clin Endocrinol (Oxf)
Objectives LMNA variants have been previously associated with cardiac abnormalities independent of lipodystrophy. We aimed to assess cardiac impact of familial partial lipodystrophy (FPLD) to understand the role of laminopathy in cardiac manifestatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f6e9c30dacf5be14fe58041d909199
https://hdl.handle.net/11454/69637
https://hdl.handle.net/11454/69637
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
SAT-622 Heterogeneity of Familial Partial Lipodystrophy Type 2 from a Genotype-Phenotype Perspective
Autor:
Maria Cristina Foss de Freitas, Elif A. Oral, Baris Akinci, Ormond A. MacDougald, Abdelwahab Jalal Eldin, Callie A.S. Corsa
Publikováno v:
Journal of the Endocrine Society
Phenotypic heterogeneity is a well-known feature of Familial Partial Lipodystrophy Type 2 (FPLD2) which is caused by pathogenic variants in the LMNA gene. Clinical diagnosis can be challenging in some cases. Likewise, trained physicians can report di
Autor:
Mario Swaidan, Maria Cristina Foss de Freitas, Baris Akinci, Yingying Luo, Abdelwahab Jalal Eldin, Elif A. Oral, Rita Hench, Nevin Ajluni, Adam H. Neidert
Publikováno v:
Journal of the Endocrine Society
Introduction Metreleptin treatment may improve the metabolic aspects of partial lipodystrophy; however, the treatment response is heterogeneous. This study aimed to explore changes in circulating apolipoprotein concentrations, as well as ANGPLT3, ANG